calendar

4 catalysts · 4 approval

next 91 dayslessmore

MonWedFri

view

sort

Week of May 2, 2022

4

May 4, 2022approval1560d agoPOMALIDOMIDE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

May 4, 2022approval1560d agoENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvaltrastuzumab deruxtecan

Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION

May 4, 2022approval1560d agoENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvaltrastuzumab deruxtecan

Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION

May 4, 2022approval1560d agoTAMSULOSIN HYDROCHLORIDE — FDA approvalTAMSULOSIN HYDROCHLORIDE

Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL